Private placements are a way for companies to raise capital directly from investors. For Leap Therapeutics, this $40 million infusion can be crucial for funding its research and development projects or expanding its operations, which in turn could positively impact its stock price in the short term as it demonstrates the company's ability to secure funding and potentially enhance its future growth prospects.